Quantification of tumor cell injury in vitro and in vivo using expression of green fluorescent protein under the control of the GADD153 promoter

International Journal of Cancer

Volumn 91, Issue 4, 2001, Pages 555-562

  Lin, Xinjian ^a,b   Gately, Dennis P ^a,b   Hom, Doreen ^a   Mishima, Misako ^a   Los, Gerrit ^a   Howell, Stephen B ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b BIOGEN   (United States)

Author keywords

Cellular injury responses; DNA damaging inducible gene GADD153; Enhanced green fluorescent protein; Growth arrest; MNNG; Platinum drugs

Indexed keywords

CELL PROTEIN; CISPLATIN; GREEN FLUORESCENT PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; METHYLNITRONITROSOGUANIDINE; OXYGEN RADICAL; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA ADDUCT; DNA CROSS LINKING; DNA DAMAGE; DRUG POTENCY; FLOW CYTOMETRY; GAMMA RADIATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME; GENOTOXICITY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROMOTER REGION; ULTRAVIOLET RADIATION;

ANIMALS; ANOXIA; ANTINEOPLASTIC AGENTS; CCAAT-ENHANCER-BINDING PROTEINS; CELL CYCLE; CISPLATIN; CROSS-LINKING REAGENTS; DNA; DNA ADDUCTS; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GAMMA RAYS; GENES, REPORTER; GENETIC VECTORS; GENOME; GREEN FLUORESCENT PROTEINS; HEAD AND NECK NEOPLASMS; HUMANS; KINETICS; LUMINESCENT PROTEINS; METHYLNITRONITROSOGUANIDINE; MICE; MICE, NUDE; PLASMIDS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS;

EID: 0035865999     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1083>3.0.CO;2-Q     Document Type: Article

References (33)

1. Induction DNA repair systems
2. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae
3. The weel protein kinase is required for radiation-induced mitotic delay
4. Response to adversity: Molecular control of gene activation following genotoxic stress
5. DNA damage-inducible transcripts in mammalian cells
6. Mammalian genes coordinately regulated by growth arrest signal and DNA damaging agents
7. Isolation, characterization and chromosomal localization of the human GADD153 gene
8. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant negative inhibitor of gene transcription
9. Isolation and characterization of the hamster gadd153 gene
10. Activation of the gadd153 promoter by genotoxic agents: A rapid and specific response to DNA damage
11. Induction of growth arrest and DNA damage inducible gene gadd153 by cisplatin in vitro and in vivo
12. Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153
13. Paclitaxel activation of the GADD153 promoter through a cellular injury response element containing an essential Sp1 binding site
14. GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells
15. Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines limiting dilution
16. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
17. Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer
18. Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein
19. FACS-optimized mutants of the green fluorescent protein(GFP)
20. The CAT-Tox (L) assay: A sensitive and specific measure of stress-induced transcript in transformed human liver cells
21. Firefly luciferase as a tool in molecular and cell biology
22. Expression of GADD153 in tumor cells and stromal cells from xenografted tumors in nude mice treated with cisplatin: Correlation with cisplatin-DNA adducts
23. Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and resistant human hepatoma cell lines
24. Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines
25. Preclinical studies identifying carboplatin as a viable cisplatin alternative
26. Cisplatin/carboplatin cross-resistance in ovarian cancer
27. Ammine/amine platinum(IV) dicarboxylates: A novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human carcinoma cell lines
28. Synthesis, physical properties and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane
29. Oxalato-platinum (1-OHP): Experimental and clinical studies
30. Role of carrier ligand in platinum resistance of human carcinoma cell lines
31. New platinum antitumor complexes
32. The role of DNA mismatch repair in platinum drug resistance